Raras
Buscar doenças, sintomas, genes...
Doença de inclusões intranucleares neuronais
ORPHA:2289CID-10 · G31.0CID-11 · 8A0YOMIM 603472DOENÇA RARA

A Doença de Inclusão Intranuclear Neuronal (NIID) é uma condição neurodegenerativa extremamente rara que afeta múltiplos sistemas do corpo. Ela se caracteriza pela presença de estruturas anormais (chamadas inclusões intranucleares) dentro do núcleo das células nervosas (neurônios) e das células de suporte (células gliais), e também pela perda dessas células nervosas.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A Doença de Inclusão Intranuclear Neuronal (NIID) é uma condição neurodegenerativa extremamente rara que afeta múltiplos sistemas do corpo. Ela se caracteriza pela presença de estruturas anormais (chamadas inclusões intranucleares) dentro do núcleo das células nervosas (neurônios) e das células de suporte (células gliais), e também pela perda dessas células nervosas.

Publicações científicas
384 artigos
Último publicado: 2026 Apr 11

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Adolescent
+ adult, childhood, infancy
🏥
SUS: Cobertura mínimaScore: 15%
CID-10: G31.0
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧠
Neurológico
10 sintomas
🦴
Ossos e articulações
2 sintomas
👁️
Olhos
2 sintomas
🫘
Rins
1 sintomas
❤️
Coração
1 sintomas
💪
Músculos
1 sintomas

+ 21 sintomas em outras categorias

Características mais comuns

93%prev.
Velocidade de condução nervosa motora diminuída
Frequência: 40/43
92%prev.
Ventriculomegalia
Frequência: 47/51
92%prev.
Leucencefalopatia
Frequência: 47/51
90%prev.
Anormalidade do movimento
Muito frequente (99-80%)
90%prev.
Anormalidade da fala ou vocalização
Muito frequente (99-80%)
90%prev.
Anormalidade no EMG
Muito frequente (99-80%)
39sintomas
Muito frequente (6)
Frequente (17)
Ocasional (10)
Muito raro (1)
Sem dados (5)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 39 características clínicas mais associadas, ordenadas por frequência.

Velocidade de condução nervosa motora diminuídaDecreased motor nerve conduction velocity
Frequência: 40/4393%
VentriculomegaliaVentriculomegaly
Frequência: 47/5192%
LeucencefalopatiaLeukoencephalopathy
Frequência: 47/5192%
Anormalidade do movimentoAbnormality of movement
Muito frequente (99-80%)90%
Anormalidade da fala ou vocalizaçãoAbnormality of speech or vocalization
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico384PubMed
Últimos 10 anos200publicações
Pico202454 papers
Linha do tempo
2026Hoje · 2026🧪 2018Primeiro ensaio clínico📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal dominant.

NOTCH2NLCNotch homolog 2 N-terminal-like protein CDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Human-specific protein that promotes neural progenitor proliferation and evolutionary expansion of the brain neocortex by regulating the Notch signaling pathway (PubMed:29561261, PubMed:29856954, PubMed:29856955). Able to promote neural progenitor self-renewal, possibly by down-regulating neuronal differentiation genes, thereby delaying the differentiation of neuronal progenitors and leading to an overall final increase in neuronal production (PubMed:29856954). Acts by enhancing the Notch signal

LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (2)
Expression of NOTCH2NL genesNOTCH2 Activation and Transmission of Signal to the Nucleus
MECANISMO DE DOENÇA

Neuronal intranuclear inclusion disease

An autosomal dominant, slowly progressive, neurodegenerative disease characterized by eosinophilic hyaline intranuclear inclusions in the central and peripheral nervous system, and also in the visceral organs. Clinical manifestations are variable and include pyramidal and extrapyramidal symptoms, cerebellar ataxia, cognitive decline and dementia, peripheral neuropathy, and autonomic dysfunction.

INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (4)
oculopharyngodistal myopathy 3tremor, hereditary essential, 6neuronal intranuclear inclusion diseaseoculopharyngodistal myopathy
HGNC:53924UniProt:P0DPK4

Variantes genéticas (ClinVar)

4 variantes patogênicas registradas no ClinVar.

🧬 NOTCH2NLC: NM_001364012.2:c.-164GGC[(66_517)] ()
🧬 NOTCH2NLC: GRCh38/hg38 1q21.1-21.2(chr1:143515074-149563337)x1 ()
🧬 NOTCH2NLC: GRCh38/hg38 1q21.1-21.2(chr1:143965076-149471555)x3 ()
🧬 NOTCH2NLC: GRCh38/hg38 1p11.2-q22(chr1:120836007-149583533)x3 ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 1 variantes classificadas pelo ClinVar.

1
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
NOTCH2NLC: NM_001364012.2:c.-164GGC[(66_517)] [Pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Doença de inclusões intranucleares neuronais

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

1 ensaios clínicos encontrados.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

🥈Melhor nível de evidência: Ensaio clínico
Timeline de publicações
350 papers (10 anos)
#1

Genotype-phenotype correlations in neuronal intranuclear inclusion disease-related retinopathy with CGG repeat increases in NOTCH2NLC.

Journal of neurology2026 Feb 28

To report the genotype-phenotype correlations in neuronal intranuclear inclusion disease (NIID)-related retinopathy. 13 patients from 12 families (62-81 years) clinically diagnosed with late-onset NIID were studied. Best-corrected visual acuity (BCVA), Goldmann perimetry, fundus photography, fundus autofluorescence (FAF), optical coherence tomography (OCT), and full-field electroretinography (ERGs) were examined. The number of CGG repeats in NOTCH2NLC was determined. Genotype-phenotype correlations between the number of CGG repeats and the age at onset of ocular symptoms, disease duration, ellipsoid zone (EZ) length of photoreceptors in the peripapillary area, and ERGs amplitudes were determined. All patients had expanded CGG repeats (100-177 repeat units) in the NOTCH2NLC, and 11 patients noticed ocular symptoms before cognitive decline and two noticed them in their 20 s. FAF decrease and EZ absence in the peripapillary area were observed in all cases. ERGs indicated rod-cone dysfunction. The number of repeats was significantly correlated with an amplitude of all components of scotopic and photopic ERGs except for the b-wave in dark-adapted (DA) 0.01 and DA 10.0 ERGs. The highest coefficient of correlation was found between the amplitudes of the d-wave, a-wave, and the b-wave in light-adapted (LA) ON-OFF ERG (ρ = -0.97, P < 0.001, ρ = -0.92, P < 0.01, ρ = -0.84, P < 0.01 respectively), the b-wave in LA 3.0 (ρ = -0.75, P < 0.01), and 30 Hz flicker (ρ = -0.71, P < 0.05). Expanded CGG repeats in NOTCH2NLC develop ocular symptoms earlier than reported. The number of repeats can be a biomarker for the severity of retinal dysfunction in NIID-related retinopathy.

#2

Recurrent migraine with visual aura as the primary phenotype of familial neuronal intranuclear inclusion disease.

Frontiers in neurology2026

Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disorder characterized by highly heterogeneous clinical manifestations and multi-system involvement. The most common initial symptoms include tremor, cognitive impairment, and muscle weakness. Characteristic neuroimaging features comprise symmetrical diffusion-weighted imaging (DWI) high signal intensity in the corticomedullary junction and extensive leukoencephalopathy. NIID manifesting as migraine with visual aura as the predominant symptom has rarely been reported. In this study, we describe a Chinese NIID pedigree comprising eight affected members, all of whom consistently exhibited migraine with visual aura as the primary clinical feature. Notably, none of the followed-up patients showed abnormalities on neuroimaging. In one case, serial follow-up over 7 years revealed no abnormal DWI high signal intensity at the corticomedullary junction or leukoencephalopathy. Skin biopsies confirmed the presence of neuronal intranuclear inclusions in two affected patients within this pedigree. Genetic testing for the NIID-causing mutation identified the GGC repeat expansion in the NOTCH2NLC gene in three patients in this family. This study provides new insights into the phenotypic complexity of NIID.

#3

PML targets and resolves structured protein inclusions to mitigate neurodegeneration.

Nature cell biology2026 Mar

Intranuclear inclusions are defining features of many neurodegenerative diseases, yet their assembly mechanisms and pathological roles remain poorly understood. Here, we investigate polyglycine (polyG) inclusions in neuronal intranuclear inclusion disease (NIID) and show that they recruit intrinsically disordered proteins to form stratified, immobile condensates that disrupt nuclear protein quality control and DNA damage repair. Leveraging their ordered and stepwise assembly, we identify promyelocytic leukaemia protein (PML) as a key factor that actively recognizes and eliminates polyG inclusions through chaperone-mediated disaggregation and proteasome-dependent degradation. Engineered PML variants selectively clear both nuclear and cytoplasmic aggregates, including polyG, polyGA, polyQ, TDP-43 and SOD1. Systemic PML delivery alleviates cognitive and motor deficits in mouse models of NIID and TDP-43 proteinopathy. These findings uncover a conserved spatial organization of nuclear inclusions and establish PML as a therapeutic effector for neurodegenerative diseases linked to protein aggregation.

#4

NOTCH2NLC GGC repeat expansions cause retinal neurodegeneration in neuronal intranuclear inclusion disease mouse model.

Cell &amp; bioscience2026 Feb 23

Neuronal intranuclear inclusion disease (NIID) patients frequently exhibit ocular abnormalities, yet the pathogenic mechanisms remain unclear. Using a transgenic mouse model ubiquitously expressing NOTCH2NLC with 98GGC repeats, we revealed that polyglycine aggregates, translated from the expanded GGC repeats, predominantly localize in PAX6- and RBPMS-positive cells, accompanied by retinal neurodegeneration and thinning especially in the inner retinal layers. Functional assessment through visual evoked potentials demonstrated significantly reduced amplitudes and prolonged latencies in NIID mice, indicating compromised visual pathway integrity. Transcriptomic profiling revealed dysregulation of glutathione redox homeostasis and antioxidant pathways in the NIID retina. We further demonstrated that GGC expansions induce mitochondrial abnormalities accompanied by glutathione depletion and accumulation of reactive oxygen species. Crucially, intravitreal administration of the mitochondrial-targeted antioxidant Mito-TEMPO significantly alleviated retinal damage and improved visual function. Our findings establish NOTCH2NLC GGC expansions as direct drivers of retinal pathology through mitochondrial-oxidative damage, while identifying antioxidant therapy as a promising treatment strategy for NIID-associated retinopathy.

#5

Case Report: Distinctive features of cognitive dysfunction and amelioration by antiseizure medication in neuronal intranuclear inclusion disease.

Frontiers in neuroscience2026

Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. We investigated a role of nonconvulsive status epilepticus (NCSE) in cognitive dysfunction in pathologically confirmed NIID. We also analyzed distinctive factors to differentiate NIID from Alzheimer's disease (AD). A 63-year-old man presented with transient consciousness disturbance (Day 1). For previous 6 years he had been suffering from similar episodes and gradually progressive cognitive decline. Clinical characteristics and response to antiseizure medications (ASM) were analyzed with a narrative literature review. Neurological examination showed disorientation, memory disturbance, aphasia, agraphia, and impaired visuospatial ability. On Day 27, his MMSE scored 10. Diffusion-weighted MRI showed high intensity signal in the corticomedullary junction of the frontal lobe, which could not explain his neurological manifestations. EEG showed seizure patterns arising from the bilateral occipital areas. ASM improved MMSE score to 23. Skin biopsy confirmed his diagnosis as dementia-dominant sporadic NIID. He died on Day 77. Cognitive dysfunction in visuospatial execution, manifested by impaired pentagon drawing and agraphia of both kanji (Japanese morphograms) and kana (Japanese syllabograms), its fluctuating course, and reactivity to ASM were clear distinction from AD. NCSE can accelerate cognitive decline and ASM can improve cognitive function in NIID. Cognitive evaluation using pentagon drawing and handwriting of both morphograms and syllabograms can be useful to differentiate NIID from AD.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC317 artigos no totalmostrando 196

2026

Expanding mutational and phenotypic spectrum of CST3-related leukoencephalopathy: a novel family and literature review.

Neurogenetics
2026

Teaching NeuroImage: an imaging clue for neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Neuronal intranuclear inclusion disease caused by NOTCH2NLC gene expansion: a case report and literature review.

BMC neurology
2026

Adult-onset neuronal intranuclear inclusion disease initially presenting with prominent gastrointestinal symptoms: a case report.

BMC neurology
2026

An Autopsy Case With Fragile X-Associated Tremor/Ataxia Syndrome Presenting Intranuclear Inclusion Bodies Mainly in the Limbic System.

Neuropathology : official journal of the Japanese Society of Neuropathology
2026

Cerebral structure and function changes in adult neuronal intranuclear inclusion disease: a study of 16 patients.

Brain imaging and behavior
2026

Genotype-phenotype correlations in neuronal intranuclear inclusion disease-related retinopathy with CGG repeat increases in NOTCH2NLC.

Journal of neurology
2026

Recurrent migraine with visual aura as the primary phenotype of familial neuronal intranuclear inclusion disease.

Frontiers in neurology
2026

PML targets and resolves structured protein inclusions to mitigate neurodegeneration.

Nature cell biology
2026

NOTCH2NLC GGC repeat expansions cause retinal neurodegeneration in neuronal intranuclear inclusion disease mouse model.

Cell &amp; bioscience
2026

Case Report: Distinctive features of cognitive dysfunction and amelioration by antiseizure medication in neuronal intranuclear inclusion disease.

Frontiers in neuroscience
2026

The Hsp40 cochaperone DNAJC7 regulates polyglutamine aggregation and exhibits context-dependent effects on polyglycine aggregation.

The Journal of biological chemistry
2026

Neuronal intranuclear inclusion disease: a diagnostic pitfall for MELAS.

BMC neurology
2026

Astrocyte-vascular interactions are disturbed in cerebral white matter of adult-onset neuronal intranuclear inclusion disease.

Journal of neuropathology and experimental neurology
2026

Levodopa intolerance as a potential clinical red flag for neuronal intranuclear inclusion disease (NIID) in atypical parkinsonism: a case report.

BMC neurology
2026

Proteomic Landscape of Sweat Glands in Neuronal Intranuclear Inclusion Disease Reveals a Pathogenic Triad of Abnormal Autophagy, Mitochondrial Dysfunction, and a Failed Oxidative Stress Response.

Journal of neurochemistry
2026

Neuronal intranuclear inclusion disease with stroke-mimicking onset: a case report and systematic review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2026

Plasma p-tau species are elevated in presymptomatic and symptomatic neuronal intranuclear inclusion disease.

EBioMedicine
2026

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease.

Annals of clinical and translational neurology
2026

Precise excision of expanded GGC repeats in NOTCH2NLC via CRISPR/Cas9 for treating neuronal intranuclear inclusion disease.

Nature communications
2026

Long-Standing Corticomedullary Hyperintensities in a Patient with Probable Neuronal Intranuclear Inclusion Disease.

Annals of Indian Academy of Neurology
2025

Neuronal Intranuclear Inclusion Disease Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Case Report.

Acta neurologica Taiwanica
2026

Episodic encephalopathy in NOTCH2NLC-related neuronal intranuclear inclusion disease: Clinical spectrum and a proposed classification framework.

Journal of the neurological sciences
2025

Neuronal intranuclear inclusion disease presenting with recurrent dizziness and headache: a case report with 5-year follow-up.

Frontiers in genetics
2026

[A case of neuronal intranuclear inclusion disease presenting with leukoencephalopathy after the diagnosis of Charcot-Marie-Tooth disease type 4C].

Rinsho shinkeigaku = Clinical neurology
2025

[Neuronal intranuclear inclusion disease diagnosed by brain biopsy: a clinicopathological analysis of seven cases].

Zhonghua bing li xue za zhi = Chinese journal of pathology
2025

Modeling neuronal intranuclear inclusion disease: A review of animal and human-derived cellular models and mechanistic insights.

Zoological research
2025

[A case of neuronal intranuclear inclusion disease with coexisting Alzheimer's disease biomarker signature in cerebrospinal fluid].

Rinsho shinkeigaku = Clinical neurology
2026

Bizarre astrocytes with cytoplasmic/intranuclear inclusions in an individual with alternating hemiplegia, migraine, and brain swelling associated with a GGC repeat expansion in NOTCH2NLC.

Clinical neuropathology
2025

The imperative for multigenerational genetic screening: A case report of fragile X-associated tremor/ataxia syndrome (FXTAS).

Medicine
2025

Inflammation in Neuronal Intranuclear Inclusion Disease (NIID): mechanisms, biomarkers, and therapeutic implications.

Journal of neuroinflammation
2025

Type B Fibers: A Novel Ultrastructural Biomarker for Cognitive Impairment in Neuronal Intranuclear Inclusion Disease.

Brain sciences
2025

Neuronal intranuclear inclusion disease with recurrent encephalitis.

BMC neurology
2025

[A case of neuronal intranuclear inclusion disease diagnosed 19 years after onset through clinical re-evaluation].

Rinsho shinkeigaku = Clinical neurology
2025

HnRNP M expression rescues neurodegeneration in neuronal intranuclear inclusion disease mouse model by restoring dysregulated RNA splicing and transcription.

Cell &amp; bioscience
2025

Adult-onset neuronal intranuclear inclusion disease (NIID) combined with acute ischaemic stroke: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Dual diagnosis at the neuro-immune interface: a case report of neuronal intranuclear inclusion disease with acute anti-CASPR2 encephalitis.

Frontiers in immunology
2025

Neuronal Intranuclear Inclusion Disease.

Radiology
2025

The Hsp40 co-chaperone DNAJC7 modifies polyglutamine but not polyglycine aggregation.

bioRxiv : the preprint server for biology
2025

Neuronal intranuclear inclusion disease with subtle imaging findings: a case report and literature review.

BMJ neurology open
2025

Neuronal intranuclear inclusion disease complicated by acute middle cerebral artery infarction: A case report.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
2025

NOTCH2NLC Repeat Expansions in Parkinsonian Disorders: Clinical and Neuroimaging Characteristics.

Annals of clinical and translational neurology
2025

Neuronal intranuclear inclusion disease: a dynamic evolution of MRI in 8 years and mimicker of benign paroxysmal positional vertigo.

Clinical autonomic research : official journal of the Clinical Autonomic Research Society
2025

Diverse Clinical Phenotypes of Neuronal Intranuclear Inclusion Disease in South Korea.

Journal of clinical neurology (Seoul, Korea)
2025

Generation of an induced pluripotent stem cell line (HZSMHCi002-A) from a patient with neuronal intranuclear inclusion disease carrying GGC repeat expansion in the NOTCH2NLC gene.

Stem cell research
2025

Application of Oral Mucosal Epithelial Cells in Noninvasive Pathological Diagnosis of Neuronal Intranuclear Inclusion Disease.

Neuropathology and applied neurobiology
2025

Retinal degeneration as an initial manifestation in a patient with neuronal intranuclear inclusion disease.

Documenta ophthalmologica. Advances in ophthalmology
2025

Psychiatric-onset neuronal intranuclear inclusion disease in a psychiatry-based dementia-enriched cohort in Japan.

Psychiatry and clinical neurosciences
2025

Detection and characterization of rare variants in NOTCH2NLC causing false negative molecular diagnosis through long-read sequencing.

European journal of human genetics : EJHG
2025

Vascular small fiber neuropathy in neuronal intranuclear inclusion disease.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

TAF15 and Transportin 1 in Intranuclear Inclusions of Neuronal Intranuclear Inclusion Disease.

Neuropathology and applied neurobiology
2025

Generation of an induced pluripotent stem cell line (PNUYHi003-A) from peripheral blood mononuclear cells of a patient with neuronal intranuclear inclusion disease.

Stem cell research
2025

Neuronal Intranuclear Inclusion Disease: A Confirmed Case Report and Analysis of MRI Characteristics in Three Typical Cases.

Current medical imaging
2025

Recurrent Cortical Encephalitis-Like MRI Lesion in European Descent Patient with Neuronal Intranuclear Inclusion Disease.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
2025

Recent progress in oculopharyngodistal myopathy research from clinical and genetic viewpoints.

Journal of neuromuscular diseases
2025

Identification of small fiber neuropathy in neuronal intranuclear inclusion disease: A clinicopathological study.

Alzheimer's &amp; dementia : the journal of the Alzheimer's Association
2025

uN2CpolyG-mediated p65 nuclear sequestration suppresses the NF-κB-NLRP3 pathway in neuronal intranuclear inclusion disease.

Cell communication and signaling : CCS
2025

A case of neuronal intranuclear inclusion disease (NIID) presenting with hydrocephalus-like clinical features: case report.

BMC neurology
2025

Spatial and Temporal Distribution of White Matter Lesions in NOTCH2NLC-Related Neuronal Intranuclear Inclusion Disease.

Neurology
2024

Case report: 10-year follow-up of a patient with neuronal intranuclear inclusion disease and a literature review.

Frontiers in neuroscience
2025

Peripheral neuropathy in neuronal intranuclear inclusion disease: a clinical and electrophysiological cross-sectional study.

Journal of neurology
2024

Neuronal intranuclear inclusion disease with subclinical peripheral neuropathy: A case report.

Medicine
2025

Episodic headaches and cognitive decline: uncovering neuronal intranuclear inclusion disease in a young patient.

BMJ case reports
2025

Peripheral nerve excitability abnormalities in Neuronal Intranuclear Inclusion Disease: Assessment with histopathological analysis.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
2024

A case report of neuronal intranuclear inclusion disease and literature review.

BMC neurology
2024

NOTCH2NLC GGC intermediate repeat with serine induces hypermyelination and early Parkinson's disease-like phenotypes in mice.

Molecular neurodegeneration
2024

Neuronal Intranuclear Inclusion Disease with a Corneal Disorder: A Case Report.

Medicina (Kaunas, Lithuania)
2024

Abnormalities along the cortico-medullary junction on brain MRI caused by 1,2-dichloroethane-induced toxic encephalopathy.

BMC neurology
2024

Neuronal Intranuclear Inclusion Disease Presenting with Acute-Onset Dementia and Cortical Edema: A Case Report.

Frontiers in neurology
2024

[Clinical characteristics of urinary system symptoms in 11 patients with neuronal intranuclear inclusion disease].

Zhonghua yi xue za zhi
2024

CGG Repeat Expansion in NOTCH2NLC Causing Overlapping Oculopharyngodistal Myopathy and Neuronal Intranuclear Inclusion Disease With Diffusion Weighted Imaging Abnormality in the Cerebellum.

Journal of clinical neurology (Seoul, Korea)
2024

Familial adult-onset neuronal intranuclear inclusion disease: A case report and literature review.

Medicine
2024

Diffusion and functional MRI reveal microstructural and network connectivity impairment in adult-onset neuronal intranuclear inclusion disease.

Frontiers in aging neuroscience
2025

Efficacy of deep brain stimulation for neuronal intranuclear inclusion disease tremor-dominant subtype.

Journal of neuropathology and experimental neurology
2025

Neuronal intranuclear inclusion disease in one family: clinical diversity and diagnostic challenges.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie
2025

Cerebral microbleeds in Taiwanese patients with neuronal intranuclear inclusion disease.

Brain : a journal of neurology
2024

Stroke-like episodes in patients with adult-onset neuronal intranuclear inclusion disease and patients with late-onset MELAS: A comparative study.

Annals of clinical and translational neurology
2024

Retrospective review of bladder biopsy instead of skin biopsy provided clue for the diagnosis of neuronal intranuclear inclusion disease.

Frontiers in neuroscience
2024

Case report: Sacral neuromodulation for neurogenic lower urinary tract dysfunction in patient with neuronal intranuclear inclusion disease.

Heliyon
2025

GGC repeat expansions in NOTCH2NLC cause uN2CpolyG cerebral amyloid angiopathy.

Brain : a journal of neurology
2024

Microglia contribute to polyG-dependent neurodegeneration in neuronal intranuclear inclusion disease.

Acta neuropathologica
2024

A patient with neuronal intranuclear inclusion disease combined with hypertension accompanied by elevated catecholamines.

American journal of hypertension
2024

The 5HT4R agonist velusetrag efficacy on neuropathic chronic intestinal pseudo-obstruction in PrP-SCA7-92Q transgenic mice.

Frontiers in pharmacology
2024

[Clinical and genetic analysis of a patient with Neuronal intranuclear inclusion body disease characterized by cortical enhancement in the posterior brain region].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

A family with neuronal intranuclear inclusion disease with focal segmental glomerulosclerosis.

Journal of neurology
2024

Clinical and multimodal imaging features of adult-onset neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Nerve conduction features may serve as a diagnostic clue for neuronal intranuclear inclusion disease.

Brain communications
2024

Temporal Changes in 18 F-FDG PET/CT in Familial Neuronal Intranuclear Inclusion Disease, Based on the Clinical Course.

Clinical nuclear medicine
2024

Mapping macrostructural and microstructural brain alterations in patients with neuronal intranuclear inclusion disease.

Neuroradiology
2024

Adult-onset neuronal intranuclear inclusion disease presenting with acute encephalitis-like episode and without characteristic hyperintensities on MR-DWI: a case report.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Prevalence and Characterization of NOTCH2NLC GGC Repeat Expansions in Koreans: From a Hospital Cohort Analysis to a Population-Wide Study.

Neurology. Genetics
2024

Reversible encephalitis-like episodes in fragile X-associated tremor/ataxia syndrome: a case report.

BMC neurology
2024

Advances of NOTCH2NLC Repeat Expansions and Associated Diseases: A Bibliometric and Meta-analysis.

Molecular neurobiology
2024

Clinical features of neuronal intranuclear inclusion disease with seizures: a systematic literature review.

Frontiers in neurology
2024

Ultra-high-field 7-Tesla magnetic resonance imaging in fragile X tremor/ataxia syndrome (FXTAS).

The neuroradiology journal
2024

Blepharoptosis As an Early Manifestation of Neuronal Intranuclear Inclusion Disease.

Internal medicine (Tokyo, Japan)
2024

Review of Phenotypic Heterogeneity of Neuronal Intranuclear Inclusion Disease and NOTCH2NLC-Related GGC Repeat Expansion Disorders.

Neurology. Genetics
2024

Neuronal intranuclear inclusion disease in New Zealand: A novel discovery.

Journal of the neurological sciences
2024

Immune system involvement in neuronal intranuclear inclusion disease.

Neuropathology and applied neurobiology
2024

Value of neutrophil-to-lymphocyte ratio in neuronal intranuclear inclusion disease.

Heliyon
2024

Encephalitis-like episodes with cortical edema and enhancement in patients with neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

The predominance of "astrocytic" intranuclear inclusions in neuronal intranuclear inclusion disease manifesting encephalopathy-like symptoms: A case series with brain biopsy.

Neuropathology : official journal of the Japanese Society of Neuropathology
2024

A rare stroke mimic: neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2024

Neuronal intranuclear inclusion disease misdiagnosed as Parkinson's disease: a case report.

The Journal of international medical research
2024

Case report: Neuronal intranuclear inclusion disease initially mimicking reversible cerebral vasoconstriction syndrome: serial neuroimaging findings during an 11-year follow-up.

Frontiers in neurology
2024

Adult-type neuronal intranuclear inclusion disease with limb tremor onset: a case report.

Acta neurologica Belgica
2024

Neuronal Intranuclear Inclusion Disease with NOTCH2NLC GGC Repeat Expansion: A Systematic Review and Challenges of Phenotypic Characterization.

Aging and disease
2024

Proximal sensory neuropathy and cerebellar ataxia as presenting symptoms of NOTCH2NLC-related neuronal intranuclear inclusion disease.

Journal of the neurological sciences
2024

A case report of neuronal intranuclear inclusion disease presenting with urinary incontinence.

Asian journal of surgery
2024

Adult-onset neuronal intranuclear inclusion disease related retinal degeneration: a Chinese case series.

Frontiers in medicine
2024

Neuronal intranuclear inclusion disease with cerebellar white matter tau uptake and incidental meningioma.

European journal of nuclear medicine and molecular imaging
2024

Plasma neurofilament light as a promising biomarker in neuronal intranuclear inclusion disease.

Journal of neurology
2024

Pathologic changes in neuronal intranuclear inclusion disease are linked to aberrant FUS interaction under hyperosmotic stress.

Neurobiology of disease
2024

Neuronal intranuclear inclusion disease with multisystem involvement after long-term bladder dysfunction: a case report.

Acta neurologica Belgica
2024

MRI Abnormalities Identify Neuronal Intranuclear Inclusion Disease.

Annals of neurology
2023

Neuronal Intra-nuclear Inclusion Disease.

Neurology India
2024

Utility of labial salivary gland biopsy in the histological diagnosis of neuronal intranuclear inclusion disease.

European journal of neurology
2024

MRI features of neuronal intranuclear inclusion disease, combining visual and quantitative imaging investigations.

Journal of neuroradiology = Journal de neuroradiologie
2023

Diagnostic value of nerve conduction study in NOTCH2NLC-related neuronal intranuclear inclusion disease.

Journal of the peripheral nervous system : JPNS
2023

Skin biopsy and neuronal intranuclear inclusion disease.

The Journal of dermatology
2023

Expression of expanded GGC repeats within NOTCH2NLC causes cardiac dysfunction in mouse models.

Cell &amp; bioscience
2023

Not your usual neurodegenerative disease: a case report of neuronal intranuclear inclusion disease with unconventional imaging patterns.

Frontiers in neuroscience
2023

Neuronal intranuclear inclusion disease in a 66-year-old woman.

Asian journal of surgery
2023

A case of unusual renal manifestation in a patient with neuronal intranuclear inclusion disease treated with steroids.

Clinical case reports
2023

Unilateral Wing-Beating Tremor in Neuronal Intranuclear Inclusion Disease.

Case reports in neurology
2023

Longitudinal course of hyperintensity on diffusion weighted imaging in adult-onset neuronal intranuclear inclusion disease patients.

Frontiers in neurology
2024

Neuronal intranuclear inclusion disease with cortical involvement in left hemisphere: a case report.

Wiener klinische Wochenschrift
2023

Characteristics of autonomic dysfunction in neuronal intranuclear inclusion disease.

Frontiers in neurology
2025

A case report of neuronal intranuclear inclusion disease (NIID) with MELAS-like imaging findings.

Acta neurologica Belgica
2023

Heterogenous Genetic, Clinical, and Imaging Features in Patients with Neuronal Intranuclear Inclusion Disease Carrying NOTCH2NLC Repeat Expansion.

Brain sciences
2023

The genetic and clinical spectrum in a cohort of 39 families with complex inherited peripheral neuropathies.

Journal of neurology
2023

Unilateral Hemispheric Edema and Hyperperfusion in Neuronal Intranuclear Inclusion Disease.

Neurology
2023

Case report: Neuronal intranuclear inclusion disease presenting with acute encephalopathy.

Frontiers in neurology
2023

Genetic Movement Disorders Commonly Seen in Asians.

Movement disorders clinical practice
2023

Rapidly progressive adult-onset neuronal intranuclear inclusion disease beginning with autonomic symptoms: a case report.

Frontiers in neurology
2023

First case of adult onset neuronal intranuclear inclusion disease with both typical radiological signs and NOTCH2NLC repeat expansions in a Caucasian individual.

European journal of neurology
2024

Recovery after Prolonged Disturbance of Consciousness and Repeated Cerebral Perfusion Changes in Neuronal Intranuclear Inclusion Disease.

Internal medicine (Tokyo, Japan)
2023

A comprehensive study of clinicopathological and genetic features of neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

NOTCH2NLC mutation-positive neuronal intranuclear inclusion disease with retinal dystrophy: A case report and literature review.

Medicine
2023

NOTCH2NLC GGC repeat expansion causes retinal pathology with intranuclear inclusions throughout the retina and causes visual impairment.

Acta neuropathologica communications
2023

The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Clinical Features and Classification of Neuronal Intranuclear Inclusion Disease.

Neurology. Genetics
2023

A Rare Case of Suspected Neuronal Intranuclear Inclusion Disease Requiring Differentiation From Neuro-Behçet's Disease.

Cureus
2023

Clinical, radiological, and molecular analyses of neuronal intranuclear inclusion disease with polyglycine inclusions.

Journal of the neurological sciences
2023

Clinical phenotypic diversity of NOTCH2NLC-related disease in the largest case series of inherited peripheral neuropathy in Japan.

Journal of neurology, neurosurgery, and psychiatry
2023

NOTCH2NLC GGC Repeat Expansion in Patients With Vascular Leukoencephalopathy.

Stroke
2023

Neuronal intranuclear inclusion disease with neuroimaging mimicking MELAS.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Neuronal intranuclear inclusion disease: a case report and literature review.

Acta neurologica Belgica
2023

A case report of neuronal intranuclear inclusion disease with paroxysmal peripheral neuropathy-like onset lacking typical signs on diffusion-weighted imaging.

Frontiers in neurology
2023

GGC repeat expansion in NOTCH2NLC induces dysfunction in ribosome biogenesis and translation.

Brain : a journal of neurology
2023

Autonomic dysfunction-dominant phenotype in a Chinese family with biallelic GGC repeat expansions in NOTCH2NLC.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Current advances in neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

A comment on a case report about perfusion abnormality in neuronal intranuclear inclusion disease with stroke-like episode.

Cerebral circulation - cognition and behavior
2023

Skin biopsies for diagnosing neuronal intranuclear inclusion disease: A retrospective study of 12 cases.

The Journal of dermatology
2023

Neuronal intranuclear inclusion disease mimicking progressive supranuclear palsy.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2023

Intermediate-Length GGC Repeat Expansion in NOTCH2NLC Was Identified in Chinese Patients with Amyotrophic Lateral Sclerosis.

Brain sciences
2023

Recent advances in CGG repeat diseases and a proposal of fragile X-associated tremor/ataxia syndrome, neuronal intranuclear inclusion disease, and oculophryngodistal myopathy (FNOP) spectrum disorder.

Journal of human genetics
2023

Proteomic profile of nuclei containing p62-positive inclusions in a patient with neuronal intranuclear inclusion disease.

Neurobiology of disease
2022

General Anesthesia in a Patient With Neuronal Intranuclear Inclusion Disease: A Case Report.

A&amp;A practice
2022

Unraveling rare form of adult-onset NIID by characteristic brain MRI features: A single-center retrospective review.

Frontiers in neurology
2022

Characteristic cerebral perfusion pattern in neuronal intranuclear inclusion disease.

Frontiers in neuroscience
2022

Clinical characteristics of two patients with neuronal intranuclear inclusion disease and literature review.

Frontiers in neuroscience
2022

Clinical-neuroimaging-pathological relationship analysis of adult onset Neuronal Intranuclear Inclusion Disease (NIID).

BMC neurology
2023

CSF P-Tau181 and Other Biomarkers in Patients With Neuronal Intranuclear Inclusion Disease.

Neurology
2022

Typical imaging manifestation of neuronal intranuclear inclusion disease in a man with unsteady gait: A case report.

World journal of clinical cases
2023

Neuropathological features of adult-onset neuronal intranuclear inclusion disease with fluid-attenuated inversion recovery high-intensity signals in the cerebellar paravermal area from an early stage: A case report.

Clinical neuropathology
2022

Expression of expanded GGC repeats within NOTCH2NLC causes behavioral deficits and neurodegeneration in a mouse model of neuronal intranuclear inclusion disease.

Science advances
2022

Case report: Two siblings with neuronal intranuclear inclusion disease exhibiting distinct clinicoradiological findings.

Frontiers in neurology
2022

Perfusion abnormality in neuronal intranuclear inclusion disease with stroke-like episode: A case report.

Cerebral circulation - cognition and behavior
2022

Recurrent headache and visual symptoms in a young man: a rare neuronal intranuclear inclusion disease case report.

BMC neurology
2022

Adult-Onset Neuronal Intranuclear Inclusion Disease with Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like (MELAS-like) Episode: A Case Report and Review of Literature.

Brain sciences
2023

Acute Reversible Encephalopathy with Neuronal Intranuclear Inclusion Disease Diagnosed by a Brain Biopsy: Inferring the Mechanism of Encephalopathy from Radiological and Histological Findings.

Internal medicine (Tokyo, Japan)
2023

Subclinical peripheral neuropathy is common in neuronal intranuclear inclusion disease with dominant encephalopathy.

European journal of neurology
2022

Deep Brain Stimulation on Neuronal Intranuclear Inclusion Disease-Related Tremor: A Double-Edged Impact?

Movement disorders clinical practice
2022

Generation of an induced pluripotent stem cell JTUi005-A from a patient with neuronal intranuclear inclusion disease.

Stem cell research
2022

Intermediate-length CGG repeat expansion in NOTCH2NLC is associated with pathologically confirmed Alzheimer's disease.

Neurobiology of aging
2023

NOTCH2NLC expanded GGC repeats in patients with cerebral small vessel disease.

Stroke and vascular neurology
2022

CGG repeat expansion in NOTCH2NLC causes mitochondrial dysfunction and progressive neurodegeneration in Drosophila model.

Proceedings of the National Academy of Sciences of the United States of America
2022

Diffuse Cortical Injury and Basal Ganglia High Signals on Diffusion-Weighted Imaging in Neuronal Intranuclear Inclusion Disease.

JAMA neurology
2022

Imaging findings and pathological correlations of subacute encephalopathy with neuronal intranuclear inclusion disease-Case report.

Radiology case reports
2022

Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Frontiers in aging neuroscience
2022

Urine cytological study in patients with clinicopathologically confirmed neuronal intranuclear inclusion disease.

Frontiers in aging neuroscience
2023

First detailed case report of a pediatric patient with neuronal intranuclear inclusion disease diagnosed by NOTCH2NLC genetic testing.

Brain &amp; development
2022

Clinical features of NOTCH2NLC-related neuronal intranuclear inclusion disease.

Journal of neurology, neurosurgery, and psychiatry
2022

Teaching NeuroImage: Occipital Cortical Enhancement During Encephalopathy-like Episode in Neuronal Intranuclear Inclusion Disease.

Neurology
2022

Clinical features and reclassification of essential tremor with NOTCH2NLC GGC repeat expansions based on a long-term follow-up.

European journal of neurology
2022

Patients with biallelic GGC repeat expansions in NOTCH2NLC exhibiting a typical neuronal intranuclear inclusion disease phenotype.

Genomics
2022

Case report: Adult-onset neuronal intranuclear inclusion disease with an amyotrophic lateral sclerosis phenotype.

Frontiers in neuroscience
2022

DNA hypermethylation of NOTCH2NLC in neuronal intranuclear inclusion disease: a case-control study.

Journal of neurology
2022

Absence of diffusion-weighted imaging abnormalities in a patient with neuronal intranuclear inclusion disease.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2022

Teaching NeuroImage: Paravermal Lesions in Neuronal Intranuclear Inclusion Disease.

Neurology
2022

Generation of an induced pluripotent stem cell line (ZZUi036-A) derived from skin fibroblasts of a Neuronal intranuclear inclusion disease patient with GGC repeat expansion in the NOTCH2NLC gene.

Stem cell research
2022

Neuronal Intranuclear Inclusion Disease-Related Neurotrophic Keratitis: A Case Report.

Brain sciences
2022

The polyG diseases: a new disease entity.

Acta neuropathologica communications
2022

Genetic and Imaging Characteristics of a Family With Neuronal Intranuclear Inclusion Disease.

Journal of clinical neurology (Seoul, Korea)
2022

Cognitive Dysfunction in Repeat Expansion Diseases: A Review.

Frontiers in aging neuroscience
Ver todos os 317 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Doença de inclusões intranucleares neuronais.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Doença de inclusões intranucleares neuronais

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Genotype-phenotype correlations in neuronal intranuclear inclusion disease-related retinopathy with CGG repeat increases in NOTCH2NLC.
    Journal of neurology· 2026· PMID 41762300mais citado
  2. Recurrent migraine with visual aura as the primary phenotype of familial neuronal intranuclear inclusion disease.
    Frontiers in neurology· 2026· PMID 41756172mais citado
  3. PML targets and resolves structured protein inclusions to mitigate neurodegeneration.
    Nature cell biology· 2026· PMID 41741685mais citado
  4. NOTCH2NLC GGC repeat expansions cause retinal neurodegeneration in neuronal intranuclear inclusion disease mouse model.
    Cell &amp; bioscience· 2026· PMID 41731582mais citado
  5. Case Report: Distinctive features of cognitive dysfunction and amelioration by antiseizure medication in neuronal intranuclear inclusion disease.
    Frontiers in neuroscience· 2026· PMID 41716662mais citado
  6. Recurrent Bilateral Macular Edema Linked to NOTCH2NLC GGC Repeat Expansion: A Case Report.
    Am J Case Rep· 2026· PMID 41964975recente
  7. Asthma-like bronchodilator responsiveness in patients with neuronal intranuclear inclusion disease.
    Sci Rep· 2026· PMID 41957155recente
  8. ASO therapy rescues NOTCH2NLC GGC repeat expansion-induced genomic damage, 3D chromatin structural abnormalities, and senescence.
    Nat Commun· 2026· PMID 41942455recente
  9. Neuronal intranuclear inclusion disease with initial manifestation of intractable nausea and vomiting responsive to corticosteroids: a case report.
    Front Immunol· 2026· PMID 41929501recente
  10. Clinical and imaging characteristics of NOTCH3-negative CADASIL-suspected patients with NOTCH2NLC GGC repeat expansions.
    J Hum Genet· 2026· PMID 41882342recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2289(Orphanet)
  2. OMIM OMIM:603472(OMIM)
  3. MONDO:0011327(MONDO)
  4. GARD:3971(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)
  7. Q55345768(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Doença de inclusões intranucleares neuronais
Compêndio · Raras BR

Doença de inclusões intranucleares neuronais

ORPHA:2289 · MONDO:0011327
Prevalência
Unknown
Herança
Autosomal dominant
CID-10
G31.0 · Atrofia cerebral circunscrita
CID-11
Início
Adolescent, Adult, Childhood, Infancy
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C1863843
EuropePMC
Wikidata
Papers 10a
Evidência
🥈 Ensaio clínico
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades